Open AccessTocolysis in preterm labour – current recommendations
Author(s) -
Mirosław Wielgoś,
Dorota BombaOpoń
Publication year - 2014
Publication title -
ginekologia polska
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.4
H-Index - 21
eISSN - 2543-6767
pISSN - 0017-0011
DOI - 10.17772/gp/1732
Subject(s) - medicine , tocolytic agent , fenoterol , tocolytic , preterm labor , preterm labour , oxytocin , neonatal intensive care unit , obstetrics , gestation , pregnancy , pediatrics , asthma , biology , genetics
Common use of tocolytic drugs in preterm labor has not been shown to reduce the rate of neonatal mortality and morbidity Currently tocolytics should be administered in the course of a 48-h administration of antepartum glucocorticoids and/or transfer of the gravida to a center with neonatal intensive care unit. Only oxytocin receptor antagonist--atosiban and short-acting beta-agonists--fenoterol are licensed to reduce preterm uterine activity Owing to its safety and efficacy atosiban should be the first-choice tocolytic, especially in women with other diseases or multiple gestations.